FibroGen Inc

NASDAQ:FGEN 4:00:00 PM EDT

18.15

-0.52 (-2.78%)

5:59:32 PM EDT: $17.79 -0.36 (-1.98%)

Market Cap (Intraday)	1.71B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$31.98 Million
Adjusted EPS	-$0.75

See more estimates

10-Day MA	$19.43
50-Day MA	$21.75
200-Day MA	$15.87

See more pivots

FibroGen Inc Stock, NASDAQ:FGEN

409 Illinois Street, San Francisco, California 94158-2509

United States of America

Phone: +1.415.978.1200

Number of Employees: 592

http://www.fibrogen.com

Description

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.